Benefits
Sulfite Metabolism Support
Molybdenum is the cofactor for sulfite oxidase, the enzyme that converts sulfite to sulfate. Ammonium molybdate supplies molybdenum to help ensure this enzyme can support normal metabolism of sulfites and sulfur-containing compounds.
Liquid-Delivery Molybdenum Source
Because it is highly soluble, ammonium molybdate is well suited to liquid molybdenum drops that allow flexible, low-dose intake. This makes it a practical way to supply small, adjustable amounts of the mineral.
Molybdenum Cofactor Support
Ammonium molybdate provides molybdenum used to build the cofactor required by sulfite oxidase, xanthine oxidase, and aldehyde oxidase, helping maintain normal activity of these detoxification and purine-processing enzymes.
Maintains Adequate Molybdenum Status
For individuals with low molybdenum intake, ammonium molybdate offers a well-absorbed source that helps maintain adequate levels of this essential trace mineral and the enzymes that depend on its cofactor.
Mechanism of action
Molybdenum Cofactor Formation
Molybdate from ammonium molybdate is incorporated into the pterin-based molybdenum cofactor (Moco), the prosthetic group that activates all human molybdenum-dependent enzymes and sets their maximal activity.
Sulfite Oxidase Activation
Using the molybdenum cofactor, sulfite oxidase oxidizes sulfite to sulfate, a step essential for safe metabolism of sulfur amino acids and the molybdenum function most clearly important to human health.
Xanthine and Aldehyde Oxidase Function
Molybdenum cofactor also enables xanthine oxidase and aldehyde oxidase, which convert purines to uric acid and process aldehydes and some drugs, contributing to nitrogen handling and xenobiotic metabolism.
Efficient Absorption and Excretion
As a soluble salt, molybdate is efficiently absorbed and its body level is regulated mainly through urinary excretion, keeping cofactor supply stable and buffering against both inadequate and excessive intake.
Clinical trials
Clinical case report of a patient on prolonged molybdenum-free total parenteral nutrition who developed sulfur amino-acid intolerance and was treated with supplemental ammonium molybdate (300 mcg/day).
Single long-term total parenteral nutrition patient.
The patient showed high methionine, low uric acid, and neurological symptoms consistent with impaired sulfite oxidase activity; ammonium molybdate normalized sulfur metabolism and resolved symptoms. This case used ammonium molybdate specifically and is the key human evidence for molybdenum essentiality.
Controlled metabolic study using stable molybdenum isotopes in young men across low and high intakes, measuring absorption, urinary excretion, and retention during depletion and repletion.
Healthy young men in a metabolic ward.
Soluble molybdenum was efficiently absorbed across a wide intake range, with the body regulating status through urinary excretion. The findings apply to soluble forms such as ammonium molybdate, supporting high bioavailability, though they are not specific to this exact compound.